UPDATE: Medifirst Solutions Announces New Consulting Agreement for Its Specialty Drug Division
Freehold, NJ, Aug. 02, 2018 (GLOBE NEWSWIRE) -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (OTC: MFSTD) (the “Company” or “Medifirst”), a provider of innovative laser technology and specialty pharmacy drug and consulting services, is pleased to announce that Concierge Concepts Rx (CCRx), a division of Medifirst Solutions, has signed an exclusive three-year Specialty Pharmacy Consulting Agreement with QuickChek, a New Jersey based company that owns 153 convenience stores including pharmacy services. They have 4000 employees in New Jersey and New York locations. As part of the agreement, CCRx will provide consulting services to QuickChek pharmacies so they can enter and participate in the ever-expanding market of specialty drugs. CCRx will provide services that include: clinical review, expedited medical insurance verification, training for drug dispensing, insurance billing, collections, and reconciliation. The billing services will address any denials and include appeals and re-submissions. Commented CCRx President Walter Molokie, “We plan to bring in new business and revenue streams to the QuickChek line of pharmacies and develop as well as implement a new sales strategy to generate sales for specialty drugs. We are excited and very pleased to be working with QuickChek, a company of great quality and outstanding service to the community. Additionally, we are very confident that our strategy to expand their pharmacy services will result in increased revenues.” Commented Medifirst President Bruce J. Schoengood, “We believe CCRx, with its focus on specialty drugs, can provide great growth for Medifirst as well as open up many doors for new related opportunities. Many companies have been contacting CCRx to inquire about its services and expertise and we anticipate additional announcements and further updates on QuickChek in the upcoming days and weeks.” About CCRx Specialty drugs, often described as prescription drugs that are difficult to manufacture and require special handling or administration, have limited distribution, target a narrow group of chronic diseases, are costly, and require ongoing clinical support, we believe, will drive nearly all the pharmaceutical industry’s market growth from 2015–2020. Industry analysts project the total pharmaceutical industry to exceed $483 billion in 2020, with specialty pharmaceuticals making up 44% of the revenue. If these projections hold true, specialty drugs will have increased their revenues by over 5X from 2010–2020, growing from just 15% of the market to nearly half in that decade. About The Time Machine Laser Forward-Looking Statements: Contact: Investor Relations Phone: (732) 786-8044 Email: admin@medifirstsolutions.com Website: www.medifirstsolutions.com |
|